Radiol 2291020222
Radiol 2291020222
Radiol 2291020222
Radiology
1
From the Department of Radiology, The first percutaneous vertebroplasty of which we are aware was performed in Europe in
University of Virginia Health Sciences
1984 and reported in the literature in 1987 (1), and the first vertebroplasty in North
Center, PO Box 800170, Charlottes-
ville, VA 22908. Received March 26, America was performed in 1993 and reported in 1997 (2). There are currently over 253
2002; revision requested June 5; revi- published reports focused on vertebroplasty. Most of the literature regarding percutaneous
sion received September 26; accepted vertebroplasty is based on results in early technical reports (2,3) and case series (4), which
November 6. Address correspon- include methods for patient selection, procedural details, and postprocedural care. Since
dence to M.E.J. (e-mail: mej4u@virginia
.edu). the time these previous studies were published, numerous modifications in patient eval-
M.E.J. is a paid consultant (co-chair of
uation and procedural technique have been made to better define the appropriate patient
the Scientific Advisory Board) for Par- population, to decrease surgery time, and to optimize overall patient care. Some of these
allax Medical, which makes vertebro- modifications have been published in the literature, but many have not.
plasty products, and a shareholder in Our target audience for this review is current practitioners of vertebroplasty who already
the company that owns Parallax Med-
have some knowledge of the basic indications, techniques, and vertebroplasty literature.
ical.
Our goal is to identify specific areas where the approach to vertebroplasty has changed
Current address:
2
Department of Radiology, Mayo substantially over the past several years, with an emphasis on technical changes and
Clinic, Rochester, Minn. clinical research. In addition, the current state of evidence on the efficacy of vertebroplasty
© RSNA, 2003 will be discussed, with specific focus on the need for future clinical trials.
While this review, by necessity, contains our biases and opinions on the ideal way to run
a vertebroplasty service, we do not want to imply that our techniques are the only valid
ones. However, as it will become clear in the following review, we have made substantial
efforts recently to justify our methods by careful study of our clinical database, which
comprises approximately 530 treatment levels in 320 unique patients, and to report
important lessons from these studies.
A listing of appropriate clinical features for patients being considered for vertebroplasty
can be found in the American College of Radiology Standards 2000 –2001 (5). In our practice,
by and large, we adhere to clinical indications in the American College of Radiology
standards. However, our approach to patient evaluation has changed substantially since
1993. During the early development period of percutaneous vertebroplasty, the typical
patient presented with subacute or chronic back pain that was unresponsive to medical
therapy, with a new fracture documented on a conventional radiograph (2). Selection
criteria included focal discomfort at palpation over the spinous process of the involved
vertebra and absence of radicular symptoms or neurologic deficits. Computed tomography
(CT) or magnetic resonance (MR) imaging was often performed to evaluate for nerve root
compression or retropulsed fragments. While most of these features are still considered
relevant in the patient work-up, substantial changes in our approach to patient selection
have been made on the basis of our clinical experience. These revisions involve imaging
evaluation, physical examination, and determination of the duration of pain prior to the
performance of vertebroplasty.
27
Radiology
Figure 1. Images in an elderly woman with low back pain. (a) Lateral radiograph shows multiple lumbar compression fractures of indeterminate
age. Clinical examination demonstrated nonfocal tenderness over the lower back. (b) Posteroanterior and oblique bone scan images show marked
uptake at L1 (arrows). After treatment of this single vertebra, the patient’s pain was relieved.
Adjunctive Imaging for multiple fractures of uncertain age (Fig 1). fragments. Canal compromise from ret-
Identification of Symptomatic In some cases, especially with multiple ropulsed bone is not considered an abso-
Fractures severe compression fractures, exact label- lute contraindication, provided there is
ing of vertebrae on bone scans is difficult, no cord or nerve root compression or
Although much has been written about
although use of a radioactive and ra- neurologic symptoms. To our knowl-
imaging procedures required prior to ver-
diopaque marker helps make identifica- edge, there are no written reports of im-
tebroplasty, the role of such imaging re-
tion possible. mediate or delayed movement of the
mains largely speculative (empiric) at this
To our knowledge, there currently ex- fracture fragment; however, if substantial
point. Patients referred to us have often
ist no data regarding the use of MR im- retropulsion is present, we will proceed
undergone a wide array of radiologic stud-
aging in the evaluation of patients for with vertebroplasty but are careful to
ies, including conventional radiography,
consideration of vertebroplasty, although keep the acrylic within the ventral aspect
bone scintigraphy, CT, and/or MR imag-
some investigators (7) have suggested that of the vertebral body and away from the
ing. We have tried to determine which
edema seen on MR images is predictive of fracture lines.
studies are the most helpful in identifying
a favorable response to vertebroplasty. CT provides information about frac-
who is most likely to respond to treatment.
Whereas MR imaging is sensitive for the ture involvement of the pedicles and pos-
Patients with a documented new or sub-
detection of acute compression fractures, terior elements, which may help deter-
acute fracture on a conventional radio-
we have noted a number of cases where mine the appropriate needle path. CT
graph and who meet the clinical criteria
MR imaging has demonstrated normal allows measurement of the pedicular di-
regarding pain pattern usually proceed to
(fatty) marrow signal intensity on T1- and ameter, which may influence the size of
vertebroplasty without undergoing other
T2-weighted images, while the bone scan the needle chosen for puncture, particu-
imaging. Adjunctive imaging is indicated
was abnormal. After treatment of the ver- larly in the more gracile thoracic vertebral
in patients with single or multiple fractures
tebrae that demonstrated increased activ- pedicles. However, we recently reviewed
of uncertain age or when serial conven-
ity, a good clinical response was noted in our series of thoracic vertebroplasties and
tional radiographs are unavailable. Results
these patients (Fig 2). However, we have found that the size of the needle used did
from physical examination alone may be
not evaluated the use of imaging tech- not result in a difference in complication
misleading in this setting. Either bone scan
niques such as short-tau inversion-recov- rate (8). Forty-seven vertebral bodies were
imaging or MR imaging is potentially use-
ery or contrast material– enhanced fat sat- treated in 34 patients. Eleven-gauge nee-
ful. There is only one published report of
urated MR imaging. What remains unclear
which we are aware regarding the use of dles were used in 40 (85%) of 47 treat-
is the appropriateness of these imaging
scintigraphy in preprocedural evaluation ments, while 13-gauge needles were used
modalities with regard to age of fracture.
of patients being considered for vertebro- in seven (15%) treatments. Postvertebro-
plasty (6). In that small retrospective se- plasty fracture involving the pedicle used
Role of CT in Vertebroplasty
ries, a high percentage of patients (94%) for needle access was noted in one (2%) of
achieved nearly complete pain relief after The primary indication for CT prior to 47 treatments; this pedicle had been tra-
vertebroplasty of those vertebral levels that vertebroplasty is to evaluate the integrity versed by using a 13-gauge needle. We
showed increased uptake of tracer, even in of the posterior wall of the vertebral body favor the larger-gauge needle over the
a challenging patient population with and to assess posterior displacement of smaller needle because, in our experi-
Opacification
Perhaps the most critical attribute that
facilitates safe vertebroplasty is excellent
opacification of cement. Authors of early
reports (1– 4) suggested use of either bar-
ium sulfate and powdered tungsten or
tantalum. We have observed that ideal
Figure 4. Needles suitable for vertebroplasty are supplied with a visualization of cement is achieved by
variety of stylets: A, single bevel; B, multibevel point; C, diamond using relatively large particles of barium,
point; D, threaded stylet. (Image courtesy of Parallax Medical.)
on the order of 1 mm in diameter, which
can be tracked easily during slow injec-
tion of cement. Smaller particles or finely
sifted opacifiers provide a gray back-
the tip of the stylet (Fig 4) and the can- an “off-label” manner. In most instances, ground to the cement, but this gray back-
nula, as well as the type of handle. We approved devices can be used in routine ground is difficult to discern against the
prefer to use a system that includes two clinical practice without the need for an overlying tissues. As such, we have aban-
types of stylets. The first stylet has a sharp investigational device exemption (IDE) doned the use of tungsten powder. Trac-
multibeveled or “diamond-shaped” tip from the FDA. If in doubt, however, it is ers (Parallax Medical) is composed of var-
and facilitates entry into the pedicle. In suggested that practitioners check with ious sizes of barium sulfate particles and
our experience, single-beveled stylets local institutional review boards prior to has been approved by the U.S. Food and
tend to slide off the pedicle. Once we starting a vertebroplasty practice. In ad- Drug Administration for cement opacifi-
have traversed the pedicle, we typically dition, it is suggested that practitioners cation. Another barium product is of-
remove the multibeveled stylet and place discuss the regulatory status of PMMA fered by Bryan (Woburn, Mass). Barium is
a single-beveled stylet. Although there with patients as part of the consent pro- already present in the Stryker-Howmedica
are no data to support this, we believe cess. Finally, if vertebroplasty is to be per- PMMA product, but it is not a sufficient
that the single bevel allows one to steer formed as part of a clinical trial, then an amount for opacification, and use of addi-
the needle tip slightly (Fig 5). IDE is required. tional barium is recommended.
Also available is a coaxial system with a There are at least four PMMA products
curved nitinol cannula (Cook, Blooming- currently available, including Secour Antibiotics
ton, Ind) for facilitating cross-midline ac- (Parallax Medical), Codman Cranioplas-
cess or specific placement (Fig 6). With tic (Johnson and Johnson, Bracknell, We routinely add tobramycin (Nebcin;
this device, care should be used to avoid England), Osteobond (Zimmer, Warsaw, Eli Lilly, Indianapolis, Ind) to the cement
puncture of the lateral wall of the verte- Ind) and Surgical Simplex P (Stryker- mixture, on the basis of information in
bral body. While most needle cannulas Howmedica, Limerick, Ireland). Impor- the surgical literature supporting this
have a square distal shape, one available tant differences are seen among these practice (17). Other practitioners advo-
cannula has a beveled distal end (Cook) products with regard to polymerization cate use of intravenously administered
that may allow one to direct cement in a time. The Stryker-Howmedica and Zim- antibiotics (7), but we reserve use of these
given direction. Multiple handle shapes for patients who are substantially immu-
mer products have relatively rapid poly-
are available, including standard grip de- nocompromised. We have encountered
merization, wherein the cement becomes
signs (Cook; Manan Medical Products, one case of iatrogenic infection, with
too viscous to inject within 5–7 minutes.
Wheeling, Ill), whereas other manufac- Staphylococcus epidermidis, among 250
This polymerization time can be pro-
turers offer novel designs such as an awl consecutive patients treated with verte-
longed by refrigerating the powdered
handle (Parallax Medical, Scotts Valley, broplasty (unpublished data, 2002). This
polymer pack and liquid monomer vial
Calif). Last, we use 10-cm-long needles in single patient was taking multiple immu-
prior to use or by placing syringes filled
most patients but favor 15-cm-long nee- nosuppressive medications and thus was
with the acrylic in an ice bath. The rapid
dles when treating lower lumbar verte- at high risk. In similar situations in the
polymerization of the cement may limit
brae in larger patients. future, we will use intravenous antibiot-
the ability to inject multiple levels with a
ics in addition to antibiotics placed into
single mix. If using the Codman product,
Vertebroplasty with PMMA the cement.
we recommend the slow-polymerization
Currently, the only biomaterial used type, which allows 17–20 minutes of
working time (unpublished data, 1999).
Injection Devices
for vertebroplasty in the United States is,
to our knowledge, PMMA. PMMA is ap- Because it takes time for the powdered Although various methods have been
proved for surgical implantation in mul- PMMA component to dissolve in the liq- proposed for cement injection, the ma-
tiple bone locations. However, there is no uid monomer, the manufacturer of Sec- jority of our experience has been gained
commercially available cement approved our recommends addition of a “solvation by using 1-mL syringes. The 1-mL sy-
for percutaneous vertebroplasty. Use of time” of approximately 2–3 minutes after ringes are inexpensive, require minimal
PMMA in vertebroplasty is performed in mixing and before injection. This added storage space, and allow exquisite tactile
Figure 5. (a) Lateral radiograph shows initial trajectory (arrow) of the needle, which places the tip anteriorly at the midportion of the vertebral
body. However, use of a beveled stylet, with bevel face pointing upward, deflects the tip downward. (b) Lateral radiograph shows that final position
of the cannula approximates the anterior inferior corner of the vertebral body (arrow).
Figure 8. Multilevel vertebroplasty in a 60-year-old woman with steroid-dependent chronic obstructive pulmonary disease,
who presented with severe midthoracic back pain unresponsive to narcotic analgesia. (a) Sagittal T1-weighted (750/12) MR
image shows three adjacent thoracic compression fractures at T7, T8, and T9. (b) Lateral radiograph shows vertebroplasty of
thoracic vertebrae. Patient’s pain resolved after vertebroplasty of all three levels. She returned 1 month later with new lumbar
pain, and a new L4 fracture was treated. (c) Patient returned 1 month later with new fractures of L1 and L2, identified on
sagittal T1-weighted (750/12) MR image, which were injected. Ultimately, she went on to fracture three more vertebral bodies.
Long-term Follow-up of Cement gle case in which there was apparent com- say et al (31) reported on a large series of
pression of the injected cement. The patients who were followed up after an
PMMA represents a permanent medical
cement morphology was unchanged in the index fracture; within 1 year after the
implant. Although there is a long history
remainder of the levels. initial fracture, approximately 25% of pa-
of surgical implantation of PMMA, scant
These data indicate that in the major- tients experienced a new fracture. Exact
literature exists regarding the long-term be-
ity of patients treated with percutaneous locations of new fractures were not re-
havior of cement as used in vertebroplasty.
vertebroplasty, there is stability of degree ported. We and others have noted that
We consider it of paramount importance
of vertebral compression, kyphosis, and approximately 20%–25% of patients re-
to understand the long-term sequelae of
cement morphology. In a minority of pa- turn with new, painful fractures after be-
cement deposition, in order to appropri-
tients, there may be progressive kyphosis ing treated with vertebroplasty (29). As
ately counsel patients and referring physi-
and compression at the treated level, noted earlier, approximately one-half of
cians prior to vertebroplasty. Grados et al
which indicates the need for prospective these new fractures are at sites not adja-
(28) reported radiographic follow-up in 34
study with complete clinical and radio- cent to the previously treated vertebra.
vertebrae treated with vertebroplasty in 25
graphic follow-up evaluation after verte- Thus, since only a minority of patients
patients at a mean follow-up of 48 months.
broplasty. return with new painful fractures, and,
They noted no progression of vertebral de-
since it is impossible to predict which
formity in any of the injected vertebrae.
levels will undergo subsequent fracture,
We performed a similar study in which we
Prophylactic Vertebroplasty we do not consider prophylactic verte-
identified 20 levels treated in 10 patients
broplasty to be justifiable. Furthermore,
who had undergone conventional radio- The notable pain relief achieved with
Medicare will not reimburse for prophy-
graphic follow-up at a mean of 1.3 years vertebroplasty raises the question of
lactic vertebroplasty at this time.
(30). Sixteen (80%) of 20 vertebral body whether we should routinely perform
compression fractures were stable with re- prophylactic vertebroplasty at nonfrac-
spect to the degree of kyphosis and com- tured levels in patients who present with
Outcomes Measures
pression. Two (10%) levels showed moder- painful fractures. Prophylactic vertebro-
ately increased central endplate collapse plasty might be justified if one could ac- The majority of studies on vertebro-
without a change in the degree of kypho- curately identify patients at extremely plasty have relied on rudimentary out-
sis. Two (10%) levels showed progressive high risk for new-onset fractures and comes measurements, typically includ-
collapse associated with increased kypho- could predict which nonfractured levels ing pain relief, change in mobility, and
sis. One of these levels represented the sin- will undergo spontaneous fracture. Lind- change in medication requirements. For
outcome of vertebroplasty. Percutaneous vertebroplasty in the treat- vascular effects of implanted acrylic bone
ment of osteoporotic vertebral compres- cement. BMJ 1971; 3:460 – 461.
sion fractures: an open prospective study. 26. Kaufmann TJ, Jensen ME, Ford G, Gill LL,
CONCLUSION J Rheumatol 1999; 26:2222–2228. Marx WF, Kallmes DF. Cardiovascular ef-
10. Jensen ME, Dion JE. Percutaneous verte- fects of polymethylmethacrylate use in
broplasty in the treatment of osteopo- percutaneous vertebroplasty. AJNR Am J
Percutaneous vertebroplasty has been rotic compression fractures. Neuroimag- Neuroradiol 2002; 23:601– 604.
embraced by the North American radiol- ing Clin N Am 2000; 10:547–568. 27. Kaufmann TJ, Jensen ME, Ford G, Gill LL,
ogy community within the past decade. 11. Silverman SL. The clinical consequences Marx WF, Kallmes DF. Cardiovascular ef-
Although the basic principles behind ver- of vertebral compression fracture. Bone fects of polymethylmethacrylate use in
1992; 13(suppl 2):S27–S31. percutaneous vertebroplasty. AJNR Am J
tebroplasty remain unchanged, the tech- 12. Patel UF, Skingle SF, Campbell GAF, Crisp Neuroradiol 2002; 23:601– 604.
nical aspects have been dramatically af- AJF, Boyle IT. Clinical profile of acute ver- 28. Grados F, Depriester C, Cayrolle G, Hardy
fected by operator experience, product tebral compression fractures in osteopo- N, Deramond H, Fardellone P. Long-term
development, and critical evaluation of rosis. Br J Rheumatol 1991; 30:418 – 421. observations of vertebral osteoporotic
13. Kaufmann TJ, Jensen ME, Schweickert fractures treated by percutaneous verte-
large series of patients. Although ques- PA, Marx WF, Kallmes DF. Age of fracture broplasty. Rheumatology (Oxford) 2000;
tions concerning the safety of vertebro- and clinical outcomes of percutaneous 39:1410 –1414.
plasty have been answered, its efficacy vertebroplasty. AJNR Am J Neuroradiol 29. Jensen ME, Kallmes DF, Short JG, et al.
and durability remain clouded owing to 2001; 22:1860 –1863. Percutaneous vertebroplasty does not in-
14. Do HM, Kallmes DF, Marx WF, Jensen crease the risk of adjacent level fracture: a
the lack of randomized controlled trials ME. Percutaneous vertebroplasty in the
and uncertainty over the role of the pla- retrospective study (abstr). In: ASNR An-
treatment of patients with vertebral os- nual Meeting Program. Oak Brook, Ill:
cebo effect. Radiologists have spear- teonecrosis (Kummell’s disease). Neuro- American Society of Neuroradiology,
headed the effort behind the validation surgical Focus/Journal of Neurosurgery 2000; 4.
1999; 7(1):article 2.
of vertebroplasty. It remains incumbent 30. Marx WF, Short JG, Kallmes DF, et al.
15. Gangi A, Kastler BA, Dietemann JL. Per- Long term plain film follow-up of pa-
on us to silence any doubts about the role cutaneous vertebroplasty guided by a tients treated with percutaneous verte-
vertebroplasty should play in patient care combination of CT and fluoroscopy.
broplasty: evaluation for changes in de-
through our continued thoughtful ques- AJNR Am J Neuroradiol 1994; 15:83– 86.
gree of vertebral compression, vertebral
tioning evaluation of this procedure. 16. Barr JD, Barr MS, Lemley TJ. Combined
kyphosis, and cement morphology. Pre-
CT and fluoroscopic guidance for percu-
sented at the ASNR 39th Annual Meeting,
taneous vertebroplasty. American Society
References Boston, Mass, April 23–27, 2001.
of Neuroradiology Annual Meeting 1996.
31. Lindsay R, Silverman SL, Cooper C, et al.
1. Galibert P, Deramond H, Rosat P, Le Gars 17. Shapiro SA. Cranioplasty, vertebral body
Risk of new vertebral fracture in the year
D. Preliminary note on the treatment of replacement, and spinal fusion with to-
following a fracture. JAMA 2001; 285:
vertebral angioma by percutaneous bramycin-impregnated methylmethacry-
acrylic vertebroplasty. Neurochirurgie late. Neurosurgery 1991; 28:789 –791. 320 –323.
1987; 33:166 –168. [French] 18. Gaughen JR Jr, Jensen ME, Schweickert 32. Lieberman IH, Dudeney S, Reinhardt MK,
2. Jensen ME, Evans AJ, Mathis JM, Kallmes PA, Kaufmann TJ, Marx W, Kallmes DF. Bell G. Initial outcome and efficacy of
DF, Cloft HJ, Dion JE. Percutaneous poly- Relevance of antecedent venography in “kyphoplasty” in the treatment of pain-
methylmethacrylate vertebroplasty in the percutaneous vertebroplasty for the treat- ful osteoporotic vertebral compression
treatment of osteoporotic vertebral body ment of osteoporotic compression frac- fractures. Spine 2001; 26:1631–1638.
compression fractures: technical aspects. tures. AJNR Am J Neuroradiol 2002; 23: 33. Fairbank JCF, Couper JF, Davies JBF,
AJNR Am J Neuroradiol 1997; 18:1897– 594 – 600. O’Brien JP. The Oswestry low back pain
1904. 19. Heatwole EV, McGraw JK, Patzik SB, et al. disability questionnaire. Physiotherapy
3. Cotten A, Boutry N, Cortet B, et al. Per- Predictive value of intraosseous venogra- 1980; 66:271–273.
cutaneous vertebroplasty: state of the art. phy prior to percutaneous vertebroplasty 34. Roland MF, Morris R. A study of the nat-
RadioGraphics 1998; 18:311–320. (abstr). J Vasc Interv Radiol 2001; 12:S11. ural history of back pain. I. Development
4. Deramond H, Depriester C, Toussaint P, 20. Kim AK, Jensen ME, Dion JE, Schweickert PA, of a reliable and sensitive measure of dis-
Galibert P. Percutaneous vertebroplasty. Kaufmann TJ, Kallmes DF. Unilateral trans- ability in low-back pain. Spine 1983;
Semin Musculoskelet Radiol 1997; 1:285– pedicular percutaneous vertebroplasty: ini- 8:141–144.
296. tial experience. Radiology 2002; 222:737– 35. Cook DJ, Guyatt GH, Adachi JD, et al.
5. Barr JD, Mathis JM, Barr MS, et al. Stan- 741. Development and validation of the mini-
dard for the performance of percutaneous 21. Belkoff SM, Mathis JM, Jasper LE, De- osteoporosis quality of life questionnaire
vertebroplasty. In: American College of ramond H. The biomechanics of verte- (OQLQ) in osteoporotic women with
Radiology standards 2000 –2001. Reston, broplasty: the effect of cement volume on back pain due to vertebral fractures: Os-
Va: American College of Radiology, 2000; mechanical behavior. Spine 2001; 26: teoporosis Quality of Life Study Group.
441– 448. 1537–1541. Osteoporos Int 1999; 10:207–213.
6. Maynard AS, Jensen ME, Schweickert PA, 22. Murphy KJF, Deramond H. Percutaneous 36. Jarvik JG, Deyo RA. Cementing the evi-
Marx WF, Short JG, Kallmes DF. Value of vertebroplasty in benign and malignant dence: time for a randomized trial of ver-
bone scan imaging in predicting pain re- disease. Neuroimaging Clin N Am 2000; tebroplasty. AJNR Am J Neuroradiol 2000;
lief from percutaneous vertebroplasty in 10:535–545. 21:1373–1374.
osteoporotic vertebral fractures. AJNR 23. Convery FR, Gunn DR, Hughes JD, Mar- 37. Gaughen JR Jr, Jensen ME, Schweickert
Am J Neuroradiol 2000; 21:1807–1812. tin WE. The relative safety of polymeth- PA, Kaufmann TJ, Marx WF, Kallmes DF.
7. Mathis JM, Barr JD, Belkoff SM, Barr MS, ylmethacrylate: a controlled clinical Lack of preoperative spinous process ten-
Jensen ME, Deramond H. Percutaneous study of randomly selected patients derness does not affect clinical success of
vertebroplasty: a developing standard of treated with Charnley and ring total hip percutaneous vertebroplasty. J Vasc In-
care for vertebral compression fractures. replacements. J Bone Joint Surg Am 1975; terv Radiol 2002; 13:1135–1138.
AJNR Am J Neuroradiol 2001; 22: 1:57– 64.
373–381. 24. McLaughlin RE, DiFazio CA, Hakala MF,